Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis

Nature Communications

Volumn 5, Issue , 2014, Pages

  Benyamin, Beben ^a,b   Esko, Tonu ^c,d   Ried, Janina S ^e   Radhakrishnan, Aparna ^f   Vermeulen, Sita H ^g   Traglia, Michela ^h,i   Gögele, Martin ^j   Anderson, Denise ^k   Broer, Linda ^l   Podmore, Clara ^m   Luan, Jian'An ^m   Kutalik, Zoltan ^n,o   Sanna, Serena ^p   Van Der Meer, Peter ^q   Tanaka, Toshiko ^r   Wang, Fudi ^s   Westra, Harm Jan ^q   Franke, Lude ^q   Mihailov, Evelin ^c,t   Milani, Lili ^c   Häldin, Jonas ^c   Winkelmann, Juliane ^e,u,v,w   Meitinger, Thomas ^e,v   Thiery, Joachim ^x,y   Peters, Annette ^e   Waldenberger, Melanie ^e   Rendon, Augusto ^f,z,aa   Jolley, Jennifer ^f,z   Sambrook, Jennifer ^f,z   Kiemeney, Lambertus A ^g   Sweep, Fred C ^g   Sala, Cinzia F ^h   Schwienbacher, Christine ^j   Pichler, Irene ^j   Hui, Jennie ^ab,ac   Demirkan, Ayse ^l,ad   Isaacs, Aaron ^l,ae   Amin, Najaf ^l   Steri, Maristella ^p   Waeber, Gérard ^af   Verweij, Niek ^q   Powell, Joseph E ^a   Nyholt, Dale R ^b   Heath, Andrew C ^ag   Madden, Pamela A F ^ag   Visscher, Peter M ^a   Wright, Margaret J ^b   Montgomery, Grant W ^b   Martin, Nicholas G ^b   Hernandez, Dena ^r   Bandinelli, Stefania ^ah   Van Der Harst, Pim ^q,ai   Uda, Manuela ^p   Vollenweider, Peter ^af   Scott, Robert A ^m   Langenberg, Claudia ^m   Wareham, Nicholas J ^m   Van Duijn, Cornelia ^l,ae,aj   Beilby, John ^ab,ac   Pramstaller, Peter P ^j,ak   Hicks, Andrew A ^j   Ouwehand, Willem H ^f,z   Oexle, Konrad ^v   Gieger, Christian ^e   Metspalu, Andres ^c   Camaschella, Clara ^h,al   Toniolo, Daniela ^h   Swinkels, Dorine W ^g   Whitfield, John B ^b   more..

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF TARTU   (Estonia)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h SAN RAFFAELE HOSPITAL   (Italy)

ⁱ INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^j University of Lubeck   (Italy)

^k UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^l ERASMUS MEDICAL CENTER   (Netherlands)

^m UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁿ UNIVERSITY OF LAUSANNE   (Switzerland)

^o SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^p Milan Unit   (Italy)

^q UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^r Laboratory of Membrane Biochemistry and Biophysics   (United States)

^s ZHEJIANG UNIVERSITY   (China)

^t UNIVERSITY OF TARTU   (Estonia)

^u STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^v TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^w Germany 3 Munich Cluster for Systems Neurology   (Germany)

^x UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^y UNIVERSITY OF LEIPZIG   (Germany)

^z NHS BLOOD AND TRANSPLANT   (United Kingdom)

^aa MRC BIOSTATISTICS UNIT   (United Kingdom)

^ab PATHWEST LABORATORY MEDICINE   (Australia)

^ac UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^ad LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^ae Center of Medical Systems Biology   (Netherlands)

^af UNIVERSITY OF LAUSANNE   (Switzerland)

^ag WASHINGTON UNIVERSITY   (United States)

^ah SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^ai ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^aj Netherlands Genomics Initiative   (Netherlands)

^ak General Central Hospital   (Italy)

^al VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABO PROTEIN; ARYLAMINE ACETYLTRANSFERASE; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CD71 ANTIGEN; FATTY ACID DESATURASE 2; HFE PROTEIN; IRON; LIPOPROTEIN; SERINE PROTEINASE; SOLUTE CARRIER FAMILY 40; TEX14 PROTEIN; TRANSCRIPTION FACTOR ARNTL; TRANSFERRIN; TRANSFERRIN RECEPTOR; TRANSFERRIN RECEPTOR 2; TRANSMEMBRANE PROTEASE SERINE 6; UNCLASSIFIED DRUG; FERRITIN; LIPID;

ANEMIA; BIOMARKER; COHORT ANALYSIS; DISEASE INCIDENCE; GENE EXPRESSION; HOMEOSTASIS; IRON; PHENOTYPE;

ANEMIA; ARTICLE; DISEASE ASSOCIATION; ERYTHROCYTE COUNT; GENE EXPRESSION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HEMOCHROMATOSIS; HOMOZYGOTE; HUMAN; IRON BLOOD LEVEL; IRON METABOLISM; IRON OVERLOAD; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); PHENOTYPIC VARIATION; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSFERRIN BLOOD LEVEL; ADULT; BLOOD; CHROMOSOME 7; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; HOMEOSTASIS; METABOLISM; PHENOTYPE; REPRODUCIBILITY;

ADULT; CHROMOSOMES, HUMAN, PAIR 7; FERRITINS; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HEMOCHROMATOSIS; HOMEOSTASIS; HUMANS; IRON; LIPIDS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TRANSFERRIN;

EID: 84923272209     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5926     Document Type: Article

References (70)

1. Miller, J. L. Iron deficiency anemia: a common and curable disease. Cold Spring Harb. Perspect. Med. 3, a011866 (2013).
2. Cherayil, B. J. Iron and immunity: immunological consequences of iron deficiency and overload. Arch. Immunol. Ther. Exp. (Warsz) 58, 407-415 (2010).
3. McCann, J. C. & Ames, B. N. An overview of evidence for a causal relation between iron deficiency during development and deficits in cognitive or behavioral function. Am. J. Clin. Nutr. 85, 931-945 (2007).
4. Swinkels, D. W., Janssen, M. C., Bergmans, J. & Marx, J. J. Hereditary hemochromatosis: genetic complexity and new diagnostic approaches. Clin. Chem. 52, 950-968 (2006).
5. Porter, J. B. & Shah, F. T. Iron overload in thalassemia and related conditions: therapeutic goals and assessment of response to chelation therapies. Hematol. Oncol. Clin. North Am. 24, 1109-1130 (2010).
6. Philippe, M. A., Ruddell, R. G. & Ramm, G. A. Role of iron in hepatic fibrosis: one piece in the puzzle. World J. Gastroenterol. 13, 4746-4754 (2007).
7. Liu, B. et al. Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation. J. Biol. Chem. 286, 4248-4256 (2011).
8. Liu, Y. et al. Mutant HFE H63D protein is associated with prolonged endoplasmic reticulum stress and increased neuronal vulnerability. J. Biol. Chem. 286, 13161-13170 (2011).
9. Nandar, W. & Connor, J. R. HFE gene variants affect iron in the brain. J. Nutr. 141, 729S-739S (2011).
10. Kunutsor, S. K., Apekey, T. A., Walley, J. & Kain, K. Ferritin levels and risk of type 2 diabetes mellitus: an updated systematic review and meta-analysis of prospective evidence. Diabetes Metab. Res. Rev. 29, 308-318 (2013).
11. Simcox, J. A. & McClain, D. A. Iron and diabetes risk. Cell Metab. 17, 329-341 (2013).
12. Ellervik, C. et al. Total mortality by elevated transferrin saturation in patients with diabetes. Diabetes Care 36, 2646-2654 (2013).
13. Ellervik, C., Tybjaerg-Hansen, A. & Nordestgaard, B. G. Total mortality by Transferrin saturation levels: two general population studies and a meta-analysis. Clin. Chem. 57, 459-466 (2011).
14. Pichler, I. et al. Serum iron levels and the risk of Parkinson disease: a mendelian randomization study. PLoS Med. 10, e1001462 (2013).
15. Rhodes, S. L. et al. Pooled analysis of iron-related genes in Parkinson's disease: Association with transferrin. Neurobiol. Dis. 62C, 172-178 (2013).
16. Whitfield, J. B. et al. Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am. J. Hum. Genet. 66, 1246-1258 (2000).
17. Traglia, M. et al. Heritability and demographic analyses in the large isolated population of Val Borbera suggest advantages in mapping complex traits genes. PLoS ONE 4, e7554 (2009).
18. Benyamin, B. et al. Common variants in TMPRSS6 are associated with iron status and erythrocyte volume. Nat. Genet. 41, 1173-1175 (2009).
19. Pichler, I. et al. Identification of a common variant in the TFR2 gene implicated in the physiological regulation of serum iron levels. Hum. Mol. Genet. 20, 1232-1240 (2011).
20. Ganesh, S. K. et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat. Genet. 41, 1191-1198 (2009).
21. Chambers, J. C. et al. Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels. Nat. Genet. 41, 1170-1172 (2009).
22. Soranzo, N. et al. A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat. Genet. 41, 1182-1190 (2009).
23. Hentze, M. W., Muckenthaler, M. U., Galy, B. & Camaschella, C. Two to tango: regulation of mammalian iron metabolism. Cell 142, 24-38 (2010).
24. Schadt, E. E. et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol. 6, e107 (2008).
25. van der Harst, P. et al. Seventy-five genetic loci influencing the human red blood cell. Nature 492, 369-375 (2012).
26. Global Lipids Genetics C et al. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45, 1274-1283 (2013).
27. Adams, P. C. et al. Hemochromatosis and iron-overload screening in a racially diverse population. New Engl. J. Med. 352, 1769-1778 (2005).
28. Skikne, B. S., Flowers, C. H. & Cook, J. D. Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood 75, 1870-1876 (1990).
29. Olthof, A. W. et al. Correlation between serum ferritin levels and liver iron concentration determined by MR imaging: impact of hematologic disease and inflammation. Magn. Reson. Imaging 25, 228-231 (2007).
30. Dehghan, A. et al. Meta-analysis of genome-wide association studies in 480 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 123, 731-738 (2011).
31. Qi, L. et al. Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes. Hum. Mol. Genet. 19, 1856-1862 (2010).
32. Teslovich, T. M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707-713 (2010).
33. Schunkert, H. et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 43, 333-338 (2011).
34. Yu, J. et al. Myotubularin-related protein 4 (MTMR4) attenuates BMP/Dpp signaling by dephosphorylation of Smad proteins. J. Biol. Chem. 288, 79-88 (2013).
35. Forejtnikova, H. et al. Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis. Blood 116, 5357-5367 (2010).
36. Ridefelt, P., Larsson, A., Rehman, J. U. & Axelsson, J. Influences of sleep and the circadian rhythm on iron-status indices. Clin. Biochem. 43, 1323-1328 (2010).
37. Unger, E. L., Earley, C. J. & Beard, J. L. Diurnal cycle influences peripheral and brain iron levels in mice. J. Appl. Physiol. (1985) 106, 187-193 (2009).
38. Schaap, C. C. et al. Diurnal rhythm rather than dietary iron mediates daily hepcidin variations. Clin. Chem. 59, 527-535 (2013).
39. Okazaki, F. et al. Circadian rhythm of transferrin receptor 1 gene expression controlled by c-Myc in colon cancer-bearing mice. Cancer Res. 70, 6238-6246 (2010).
40. Suhre, K. et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature 477, 54-60 (2011).
41. Kathiresan, S. et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41, 56-65 (2009).
42. Lemaitre, R. N. et al. Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium. PLoS Genet. 7, e1002193 (2011).
43. Merino, D. M., Ma, D. W. & Mutch, D. M. Genetic variation in lipid desaturases and its impact on the development of human disease. Lipids Health Dis. 9, 63 (2010).
44. Dupuis, J. et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat. Genet. 42, 105-116 (2010).
45. Ingelsson, E. et al. Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes 59, 1266-1275 (2010).
46. Chambers, J. C. et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat. Genet. 43, 1131-1138 (2011).
47. Waterworth, D. M. et al. Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 30, 2264-2276 (2010).
48. Shalev, H., Kapelushnik, J., Moser, A., Knobler, H. & Tamary, H. Hypocholesterolemia in chronic anemias with increased erythropoietic activity. Am. J. Hematol. 82, 199-202 (2007).
49. Saeed, O. et al. Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 32, 299-307 (2012).
50. Finn, A. V. et al. Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. J. Am. Coll. Cardiol. 59, 166-177 (2012).
51. Ahmed, U., Latham, P. S. & Oates, P. S. Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis. World J. Gastroenterol. 18, 4651-4658 (2012).
52. Laplante, M. & Sabatini, D. M. mTOR signaling in growth control and disease. Cell 149, 274-293 (2012).
53. Mleczko-Sanecka, K. et al. Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to the proliferative Ras/RAF and the nutrient-dependent mTOR signaling pathways. Blood 123, 1574-1585 (2014).
54. van Bokhoven, M. A., van Deursen, C. T. & Swinkels, D. W. Diagnosis and management of hereditary haemochromatosis. BMJ 342, c7251 (2011).
55. Whitlock, E. P., Garlitz, B. A., Harris, E. L., Beil, T. L. & Smith, P. R. Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 145, 209-223 (2006).
56. Beutler, E., Felitti, V. J., Koziol, J. A., Ho, N. J. & Gelbart, T. Penetrance of 845G-4 A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359, 211-218 (2002).
57. Allen, K. J. et al. Iron-overload-related disease in HFE hereditary hemochromatosis. New Engl. J. Med. 358, 221-230 (2008).
58. Pietrangelo, A. et al. Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes. Gastroenterology 128, 470-479 (2005).
59. Tjalsma, H. et al. Mass spectrometry analysis of hepcidin peptides in experimental mouse models. PLoS ONE 6, e16762 (2011).
60. Wallace, D. F. et al. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology 50, 1992-2000 (2009).
61. Goswami, T. & Andrews, N. C. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J. Biol. Chem. 281, 28494-28498 (2006).
62. Gao, J. et al. Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metab. 9, 217-227 (2009).
63. Scotet, V. et al. Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation. Am. J. Epidemiol. 158, 129-134 (2003).
64. Weiss, G. Genetic mechanisms and modifying factors in hereditary hemochromatosis. Nat. Rev. Gastroenterol. Hepatol. 7, 50-58 (2010).
65. Casanovas, G., Banerji, A., d'Alessio, F., Muckenthaler, M. U. & Legewie, S. A multi-scale model of hepcidin promoter regulation reveals factors controlling systemic iron homeostasis. PLoS Comput. Biol. 10, e1003421 (2014).
66. Crespo, A. C. et al. Genetic and biochemical markers in patients with Alzheimer's disease support a concerted systemic iron homeostasis dysregulation. Neurobiol. Aging 35, 777-785 (2014).
67. Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190-2191 (2010).
68. Duggal, P., Gillanders, E. M., Holmes, T. N. & Bailey-Wilson, J. E. Establishing an adjusted p-value threshold to control the family-wide type 1 error in genome wide association studies. BMC Genomics 9, 516 (2008).
69. Liu, J. Z. et al. A versatile gene-based test for genome-wide association studies. Am. J. Hum. Genet. 87, 139-145 (2010).
70. Westra, H. J. et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 45, 1238-1243 (2013).